Rollout of the first malaria vaccine, RTS,S/AS01, in Ghana, Kenya and Malawi through the landmark Malaria Vaccine Implementation Programme (MVIP) to nearly 2 million children since 2019 has resulted in substantial reduction in severe illness and child deaths. This side event will present full MVIP results after 46 months of vaccination, countries’ reflections on lessons learned that will inform broader vaccine implementation, and next steps for WHO-recommended malaria vaccines to save more lives. Join us to learn more and participate in Q&A. Speakers: WHO specialists, African-based researchers, Ministry of Health representatives, MVIP partners PATH and GSK, and Gavi.

Join here: https://us06web.zoom.us/j/81511947633?pwd=KGYemngb6AVmVKd8a6mSiyD9IVk8ehQXSX0.IJgoEysbeW53IRlq

Passcode: CPHIA@2023